You searched for "adults"

664 results found

Can amplification preserve auditory function?

Hearing loss is a noted modifiable risk factor for dementia, and is also associated with depression, decreased quality of life and isolation. Hearing aids are the main intervention for presbycusis and a 2017 Cochrane Review showed that they have a...

Persistent imbalance after traumatic brain injury is central in origin

Several residual symptoms, including dizziness and imbalance, can follow traumatic brain injury, no matter how mild. This study focused on the mechanisms, peripheral and central, underlying the complaint of persistent imbalance in patients with chronic mild traumatic brain injury (mTBI)....

Combined use of a hearing aid and a cochlear implant: a case study

When multi-channel cochlear implants (CIs) were first introduced in the 1980s, their use was restricted to people who derived no benefit from conventional amplification. Over the past three decades, however, the criteria for CIs has been relaxed considerably, and it...

The challenge of disrupting the hearing care market in the USA

Barry Freeman, an Audiology Consultant of extensive global experience, examines the business model of hearing care service delivery in America. He discusses the challenges the profession has faced, and proposes some food for thought on learning from other health care...

Diabetes and hearing loss: a review

As hearing health professionals we often ask, especially in older patients, if they have diabetes; but what is the link? How is it manifested and should it change current practice? Alec Lapira reviews the changing evidence. Early attempts to establish...

hearX is award winner in the Hearing Technology Innovator Mobile Testing category


hearX Group’s remote hearing care solution, hearX Self Test Kit, was recently announced as the Hearing Technology Innovator award winner in the Mobile Testing category, by Hearing Health & Technology Matters. With over 22,000 votes cast, the awards programme showcased a number of incredible technologies, representing companies from more than 10 different countries globally.

New TympStar Pro updates including WideBand tympanometry

Grason-Stadler, a worldwide leader of clinical audiometric systems, is pleased to announce new updates to their leading clinical tympanometer, the GSI TympStar Pro™.

Subtypes of vestibular migraine

The authors argue that the current Barany criteria (ICVD) for vestibular migraine (definite and probable – dVM and pVM) are too restrictive. For instance, whereas a category of chronic migraine with or without aura is recognised in ICHD-3, ‘chronic VM’...

CRSwNP, another monoclonal antibody

Interleukins 4, 5 and 13 were shown to be important factors in type 2 inflammation, which characterises chronic rhinosinusitis with nasal polyposis (CRSwNP). In CRSwNP non-responders and those who recur short after-surgery monoclonal antibodies might be an answer. Examples include...

Ethnic inequalities in hearing aid use

Recent events, including the COVID-19 pandemic, have once again highlighted health inequalities experienced by people from ethnic minority backgrounds. Our Editors’ Choice paper shows that there are inequalities in hearing aid use and includes the stark finding that ethnicity is...

Acute peripheral vestibulopathy: is it really neuritis?

The pathophysiology of acute vestibular dysfunction has been debated for decades. By seeking to clarify the underlying aetiology, this study muddies the waters further by advocating systemic and intratympanic steroids as first line treatment if the aetiology is uncertain. The...

Widex UK & Ireland partner with Anglia Ruskin University

Widex UK & Ireland and Anglia Ruskin University (ARU) announced in July, an exciting project designed to create added value for independent hearing care professionals and future audiology graduates within the UK & Ireland.